期刊文献+

帕罗西汀辅助治疗功能性消化不良 被引量:6

Paroxetine in the Treatment of Functional Dyspepsi
下载PDF
导出
摘要 目的:观察帕罗西汀佐治功能性消化不良(FD)的临床效果。方法:将70例FD随机分为两组,对照组(34例)予多潘立酮10mg每日3次口服,奥美拉唑20mg每日2次口服;治疗组(36例)在对照组治疗的基础上加用帕罗西汀10~20mg,每日1次口服。两组疗程均为4周,观察两组效果。结果:治疗组近期临床治愈21例,显效10例,有效3例,无效2例,近期临床治愈率为58.3%,总有效率为94.4%;对照组近期临床治愈8例,显效8例,有效10例,无效8例,近期临床治愈率为23.5%,总有效率为76.5%。两组近期临床治愈率比较差异有统计学意义(P<0.01),总有效率比较差异亦有统计学意义(P<0.05)。结论:在FD常规治疗基础上,联合帕罗西汀抗抑郁治疗,可起到协同作用,对FD有良好的疗效。 Objective:To observe the clinical effect of treating functional dyspepsia with Paroxetine. Methods:70 FD patients were randomly divided into 2 groups : the treatment group ( n = 36) and the control group( n = 34). The patients in the control group were given 10 mg of Domperidone t. i.d. and 20 mg of Prilosec twice a day orally and the patients in the treatment group were given the same medication as the control group plus 10-20 mg of Paroxetine once a day in a 4-week period of treatment. The effects between the two groups were compared. Results:In the treatment group,the short-term clinical cure rate was 58.3% (21 cases) and the total effective rate was 94.4% ( 10 excellent,3 effective and 2 invalid), In the control group the short-term cure rate was 23.5% (8 cases)and the total effective rate was 76.5% (8 excellent, 10 effective and 8 invalid). The short-trem cure rates and the total effective rates in the 2 groups showed difference of statistical significance ( P 〈 0.01 vs P 〈 0.05 ). Conclusion: Paroxetine contributes to the treatment of functional dyspepsia.
作者 骆丹
机构地区 解放军
出处 《临床误诊误治》 2009年第8期5-6,共2页 Clinical Misdiagnosis & Mistherapy
关键词 消化不良 抗抑郁药 质子泵抑制剂 胃动力药 Dyspepsia Antidepressants Proton puminhibitor Prokinetie drug
  • 相关文献

参考文献8

二级参考文献17

  • 1王果,李红艳,伍灵达.莫沙必利与氟西汀联用治疗功能性消化不良的疗效观察[J].中国综合临床,2005,21(1):20-22. 被引量:11
  • 2朱良如,谢小平,钱伟,侯晓华.5-羟色胺在胃机械感觉过敏中的作用[J].中华消化杂志,2005,25(3):166-168. 被引量:29
  • 3蔡永敏.中药药理与临床应用[M].北京:华夏出版社,1999.35.
  • 4Drossman AD.The functional gastrointestinal disorders:diagnosis,pathophysiology,and treatment:a multinational consensus.2nd ed.Lawrence:Allen Press,2000.
  • 5Gershon MD.Review article:serotonin receptors and transporters-roles in normal and abnormal gastrointestinal motility.Aliment Pharmacol Ther,2004,20(suppl 7):3-14.
  • 6Dunlop SP,Jenkins D,Neal KR,et al.Relative importance of enterochromaffin cell hyperplasia,anxiety,and depression in postinfections IBS.Gastroenterology,2003,125:1651-1659.
  • 7Crowell MD,Shetzline MA,Moses PL,et al.Enterochromaf fin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.Curr Opin Investig Drugs,2004,5:55-60.
  • 8Rantala I,Paronen I,Kainulainen H,et al.Enterochromaffin cell density in the gastric mucosa of patients with chronic renal failure.APMIS,1996,104:362-366.
  • 9Yu PL,Fujimura M,Hayashi N,et al.Mechanism in regulating the release of serotonin from the perfused rat stomach.Am J Physiol Gastrointest Liver Physiol,2001,280:G1099-G1105.
  • 10Coates MD,Mahoney CR,Linden DR,et al.Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.Gastroenterology,2004,126:1657-1664.

共引文献137

同被引文献56

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部